Tudor Investment Corporation »

Immunovant shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8M 87k 32.31
2023-12-31 $1.6M 38k 42.13
2023-06-30 $272k 14k 18.97
2023-03-31 $1.0M 67k 15.50

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Pioneer Natural Resources Co - US Equity (PXD)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Meta Platforms Inc - US Equity (META)
Spdr S&P 500 Etf Trust - US ETP Exchange-Traded Fund (SPY)
Utilities Select Sector Spdr Fund - US ETP ETF Option Put Option (XLU)
Humana Inc - US Equity (HUM)
Nvidia Corp - US Equity (NVDA)
Apple Inc - US Equity (AAPL)
Eli Lilly & Co - US Equity Option Call Option (LLY)
Unitedhealth Group Inc - US Equity (UNH)
Advanced Micro Devices Inc - US Equity (AMD)
Micron Technology Inc - US Equity (MU)
Nike Inc - US Class B Equity (NKE)

View all positions for Tudor Investment Corporation

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Perceptive Advisors
Armistice Capital
T. Rowe Price Associates
Viking Global Investors
Logos Global Management
Alpine Partners VI
Point72 Asset Management
Geode Capital Management
Woodline Partners
Fred Alger Management
Pictet Asset Management Holding SA
Rock Springs Capital Management

View all funds holding Immunovant